Рет қаралды 102
The FOXG1 Research Foundation team attended the 2024 American Society of Gene and Cell Therapy Conference in Baltimore, Maryland. CEO, Nasha Fitter shares her take-aways about this exciting time in translational science as the FOXG1 Research Foundation is working to bring a promising gene therapy for patients with FOXG1 syndrome through clinical trials.
Help support this work for FOXG1 syndrome: foxg1research.org/donate